Elsevier, Inc. Announces The Launch Of A New Journal: Bioprinting
AMSTERDAM, February 25, 2016 /PRNewswire/ --
New, multidisciplinary journal for 3D bioprinting research
Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new journal, Bioprinting. This broad-spectrum, multidisciplinary journal is geared towards all aspects of 3D fabrication technology of biological tissues, organs and cells for medical and biotechnology applications.
Issued quarterly, Bioprinting publishes high quality research papers with significant scientific novelty and impact in all areas of 3D bioprinting research.
The Editor-in-Chief of Bioprinting, Prof. Anthony Atala M.D., is Director of the Wake Forest Institute for Regenerative Medicine, and the W.H. Boyce Professor and Chair of the Department of Urology at Wake Forest University, one of the premiere facilities for regenerative medicine in the world.
Dr. Gaia Lupo, Publisher for Bioprinting, commented: "This new journal follows the tremendous success of the recent launch of the journal Additive Manufacturing, and addresses researchers' need of a dedicated publication which will be home for high quality results in all areas of 3D bioprinting research with high clinical significance.
"The new journal is uniquely positioned to bridge the gap between scientific research and clinical applications to improve human health and well-being," Dr. Lupo continued. "Bioprinting offers a unique platform to bring together engineers and physicians, and facilitate collaboration and dialogue on the entire breadth of 3D fabrication technology for biology and medicine."
Articles published in Bioprinting will be made freely available online on ScienceDirect throughout 2016.
For more information or to submit an article, go to http://www.journals.elsevier.com/bioprinting.
About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries. http://www.elsevier.com
Media contact
Emma McEwan
Marketing Communications Manager, Elsevier
+31-20-485-2485
e.mcewan@elsevier.com SOURCE Elsevier
New, multidisciplinary journal for 3D bioprinting research
Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new journal, Bioprinting. This broad-spectrum, multidisciplinary journal is geared towards all aspects of 3D fabrication technology of biological tissues, organs and cells for medical and biotechnology applications.
Issued quarterly, Bioprinting publishes high quality research papers with significant scientific novelty and impact in all areas of 3D bioprinting research.
The Editor-in-Chief of Bioprinting, Prof. Anthony Atala M.D., is Director of the Wake Forest Institute for Regenerative Medicine, and the W.H. Boyce Professor and Chair of the Department of Urology at Wake Forest University, one of the premiere facilities for regenerative medicine in the world.
Dr. Gaia Lupo, Publisher for Bioprinting, commented: "This new journal follows the tremendous success of the recent launch of the journal Additive Manufacturing, and addresses researchers' need of a dedicated publication which will be home for high quality results in all areas of 3D bioprinting research with high clinical significance.
"The new journal is uniquely positioned to bridge the gap between scientific research and clinical applications to improve human health and well-being," Dr. Lupo continued. "Bioprinting offers a unique platform to bring together engineers and physicians, and facilitate collaboration and dialogue on the entire breadth of 3D fabrication technology for biology and medicine."
Articles published in Bioprinting will be made freely available online on ScienceDirect throughout 2016.
For more information or to submit an article, go to http://www.journals.elsevier.com/bioprinting.
About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries. http://www.elsevier.com
Media contact
Emma McEwan
Marketing Communications Manager, Elsevier
+31-20-485-2485
e.mcewan@elsevier.com SOURCE Elsevier